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Final Progress Report 
 
Summary of progress made toward the achievement of the originally stated aim 
 
The funded aim targeted functional studies of human leukotriene C4 synthase (LTC4S) via 
structural studies requiring over-expression and purification of wild-type and mutant human 
LTC4S, two-dimensional (2D) crystallization, inhibition and augmentation of enzymatic function, 
and electron crystallography. 
Over-expression and purifiction of wild-type and mutant protein:  The fission yeast 
Schizosaccharomyces pombe was successfully employed for the over-expression and 
purification of the wild-type human LTC4S and its mutants R30L, R31A, and R104A.  Previously 
we had shown that the wild-type human enzyme could be purified via one-step S-
hexylglutathione affinity column chromatography.  The resulting protein was active and could be 
crystallized in 2D arrays, which were frequently several microns in diameter and highly ordered 
(Schmidt-Krey et al., 2004, Zhao et al., 2010). As the R31A and R104A mutants show 
significant reduction in function, a Ni-NTA affinity column, rather than the S-hexylglutathione 
affinity column, was employed for purification.  This change of column was also applied in the 
purification of the wild-type enzyme, when newer batches of S-hexylglutathione affinity column 
beads appeared to contain less S-hexylglutathione and thus resulted in significantly lower 
purification yields.  Both wild-type and mutant human LTC4S could be purified reproducibly in 
the milligram-range with the Ni-NTA affinity column. 
2D crystallization:  To induce 2D crystallization, the detergent-solubilized (1% Triton 
X100), purified enzyme was mixed with dimyristoyl phosphatidyl choline (DMPC) at low lipid-to-
protein (LPR) ratios and dialyzed against detergent-free buffer.  By optimization of the washing 
step of the column, additional removal of the lipid from the purified protein provided further 
control of the LPR (Johnson & Schmidt-Krey, in preparation).  Initial batches of purified protein 
resulted in 2D crystals at unusually low LPRs, indicating that lipid must have been co-purified 
(Zhao et al., 2010).  Additional washing steps during the purification allowed for a higher 
concentration of lipid to subsequently be added for crystallization. The thoroughly washed 
protein at higher LPRs for 2D crystallization, resulted in the same 2D crystal form, morphology, 
and high crystal quality as previously observed.  While occasional adjustment of the LPR was 
necessary in a newly purified protein batch, this now consistently ranges closely around LPR 15 
for the wild-type and mutant enzyme. Initially small ordered arrays of the mutants were 
observed within larger membranes, which could then be increased significantly in size by 
lowering the LPR, the same approach that was successful for the wild-type enzyme.  Activity 
measurements of the newly purified and solubilized LTC4S as well as the protein after 2D 
crystallization, regardless of LPR for samples where membranes were observed, corresponded 
to previously established activity levels. Incubation of wild-type LTC4S 2D crystals with Mg2+, 
which increases activity, and N-ethylmaleimide, which inhibits activity, demonstrated that the 2D 
crystals retain order, which is a critical step towards cryo-EM data collection (Johnson et al., 
unpublished results). 
While we had previously observed some stacking of 2D crystals of LTC4S, this appeared 
to occur mostly over time during storage, and could be circumvented for data collection by either 
selecting single-layered 2D crystals of newly prepared crystals, or by storage of freshly-made 
2D crystals in a -80°C freezer.  A major obstacle appeared when all recent purification batches 
resulted in a large number of stacked crystals during and after dialysis.  Neither biochemical 
manipulation during the purification, during dialysis, nor after dialysis could reduce or eliminate 
the stacks.  We were, however, successful with a new cryo-EM grid preparation protocol we 
developed to ‘unstack’ and thus reduce stacked crystals of LTC4S to mostly single layers, 
corresponding to one lipid bilayer containing the protein 2D crystal. 
Data collection: While single-layered LTC4S 2D crystals can now be prepared easily 
and reproducibly, in the fall of 2013 we experienced an unexpected delay due to installation of 
direct electron detectors on our collaborators’ cryo-EMs.  This is proving overall very beneficial 
though as the time of data collection is greatly reduced (days vs. months) since the enormous 
effort that previously had to be invested in the collection of images from tilted samples appears 
to have been overcome with the combination of direct electron detectors and automated drift 
correction  (Scherer et al., 2014).  In addition, we are taking a two-pronged approach for the 
structure-function studies with both electron crystallography and microED (Shi et al., 2013). 
 
List of significant results  
 
1. The over-expression and purification of mutants R30L, R31A and R104A of LTC4S was 
successful and reproducible. 
2. Mutants R31A and R104A, which show significantly decreased activity, can be induced to 
form 2D crystals comparable to wild-type LTC4S 2D crystals (Zhao et al., 2010; Johnson et al., 
2010; 2013; Johnson & Schmidt-Krey, in preparation). 
3. Wild-type LTC4S 2D crystals retain order upon incubation with Mg2+, which increases acitivity, 
and N-ethylmaleimide, which inhibits activity (Johnson et al., unpublished results). 
4. A significant set-back occurred when LTC4S formed a large majority of stacked 2D crystals, 
which at that time could not be analyzed.   
5.  A new protocol was developed for LTC4S, to reduce the stacked LTC4S 2D crystals to single 




Any resulting data will be deposited in the PDB and the EMDB. 
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